Psychiatry
ADHD
1
Pipeline Programs↗
8
Active Trials↗
3
Companies Involved↗
ADHD is an early-stage landscape with 1 program across 3 companies. The most active players are Shanghai Ark Biopharmaceutical Co., Ltd., Cingulate Therapeutics, Eli Lilly. 1 program is in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Approved
No programs
Analysis
Trial Status
29
clinical trials
Completed15 · 52%
Not yet recruiting5 · 17%
Unknown status3 · 10%
Recruiting3 · 10%
Withdrawn2 · 7%
No longer available1 · 3%
Clinical Trials
Trial Activity
29 trials
Black Seed Oil in ADHD
Not yet recruiting·—·Phase 2·NCT06542887·60 enrolled
The Impact of the MIND Diet on ADHD Symptom Severity in Children With ADHD Not on Pharmacotherapy: A Randomized Controlled Trial in Lebanon
Not yet recruiting·AAmerican University of Beirut Medical Center·Preclinical·NCT07686458·158 enrolled
Impact of Circadian Misalignment for Adolescents With ADHD: Observational and Mechanistic Data
Not yet recruiting·CChildren's Hospital Medical Center, Cincinnati·Preclinical·NCT07684417·50 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)